Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalane Kitzman

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American Heart Association|July 31, 2023
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities StudyDiego Ramonfaur, Hicham Skali, Brian Claggett, et al.
Journal of the American Geriatrics Society|April 10, 2026
Operationalizing a Decision-Making for Adverse Event Reporting Toolkit (DART) for Aging and Serious Illness ResearchSara Lubetsky, Christopher Woodrell, Gabrielle Schiller, et al.
Journal of the American College of Cardiology|November 29, 2023
Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) StudyRani Zierath, Brian Claggett, Victoria Arthur, et al.
Journal of the American College of Cardiology|May 8, 2012
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trialMona Fiuzat, Daniel Wojdyla, Dalane Kitzman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2021
Chronic Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, et al.
American Heart Journal|December 9, 2008
The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failureRoss Arena, Jonathan Myers, Joshua Abella, et al.
JAMA Cardiology|August 25, 2018
Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) StudyKotaro Nochioka, Gabriela Querejeta Roca, Brian Claggett, et al.
Journal of Computer Assisted Tomography|March 22, 2014
Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imagingJennifer H Jordan, Jason C Haag, Timothy M Morgan, et al.
Journal of the American Heart Association|May 27, 2017
Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of AtherosclerosisWesley T O'Neal, Matylda Mazur, Alain G Bertoni, et al.
Medicine and Science in Sports and Exercise|September 9, 2011
Predicting maximal HR in heart failure patients on β-blockade therapySteven J Keteyian, Dalane Kitzman, Faiez Zannad, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American Heart Association|July 31, 2023
Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities StudyDiego Ramonfaur, Hicham Skali, Brian Claggett, et al.
Journal of the American Geriatrics Society|April 10, 2026
Operationalizing a Decision-Making for Adverse Event Reporting Toolkit (DART) for Aging and Serious Illness ResearchSara Lubetsky, Christopher Woodrell, Gabrielle Schiller, et al.
Journal of the American College of Cardiology|November 29, 2023
Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) StudyRani Zierath, Brian Claggett, Victoria Arthur, et al.
Journal of the American College of Cardiology|May 8, 2012
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trialMona Fiuzat, Daniel Wojdyla, Dalane Kitzman, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2021
Chronic Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, et al.
American Heart Journal|December 9, 2008
The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failureRoss Arena, Jonathan Myers, Joshua Abella, et al.
JAMA Cardiology|August 25, 2018
Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) StudyKotaro Nochioka, Gabriela Querejeta Roca, Brian Claggett, et al.
Journal of Computer Assisted Tomography|March 22, 2014
Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imagingJennifer H Jordan, Jason C Haag, Timothy M Morgan, et al.
Journal of the American Heart Association|May 27, 2017
Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of AtherosclerosisWesley T O'Neal, Matylda Mazur, Alain G Bertoni, et al.
Medicine and Science in Sports and Exercise|September 9, 2011
Predicting maximal HR in heart failure patients on β-blockade therapySteven J Keteyian, Dalane Kitzman, Faiez Zannad, et al.
Pageof 6